1325 related articles for article (PubMed ID: 10508281)
1. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.
Tofts PS; Brix G; Buckley DL; Evelhoch JL; Henderson E; Knopp MV; Larsson HB; Lee TY; Mayr NA; Parker GJ; Port RE; Taylor J; Weisskoff RM
J Magn Reson Imaging; 1999 Sep; 10(3):223-32. PubMed ID: 10508281
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
[TBL] [Abstract][Full Text] [Related]
3. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.
Tofts PS
J Magn Reson Imaging; 1997; 7(1):91-101. PubMed ID: 9039598
[TBL] [Abstract][Full Text] [Related]
4. Flow versus permeability weighting in estimating the forward volumetric transfer constant (K
Li CH; Chen FH; Schellingerhout D; Lin YS; Hong JH; Liu HL
Magn Reson Imaging; 2017 Feb; 36():105-111. PubMed ID: 27989901
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG
Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
[TBL] [Abstract][Full Text] [Related]
6. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
7. Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging.
Murase K
Magn Reson Med; 2004 Apr; 51(4):858-62. PubMed ID: 15065262
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the effect of haematocrit-dependent arterial input functions on the accuracy of pharmacokinetic parameters in dynamic contrast-enhanced MRI.
Just N; Koh DM; D'Arcy J; Collins DJ; Leach MO
NMR Biomed; 2011 Aug; 24(7):902-15. PubMed ID: 21290457
[TBL] [Abstract][Full Text] [Related]
9. Model selection for DCE-T1 studies in glioblastoma.
Bagher-Ebadian H; Jain R; Nejad-Davarani SP; Mikkelsen T; Lu M; Jiang Q; Scarpace L; Arbab AS; Narang J; Soltanian-Zadeh H; Paudyal R; Ewing JR
Magn Reson Med; 2012 Jul; 68(1):241-51. PubMed ID: 22127934
[TBL] [Abstract][Full Text] [Related]
10. Impact of transvascular and cellular-interstitial water exchange on dynamic contrast-enhanced magnetic resonance imaging estimates of blood to tissue transfer constant and blood plasma volume.
Paudyal R; Poptani H; Cai K; Zhou R; Glickson JD
J Magn Reson Imaging; 2013 Feb; 37(2):435-44. PubMed ID: 23197427
[TBL] [Abstract][Full Text] [Related]
11. A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: application in carcinoma of the cervix.
Donaldson SB; West CM; Davidson SE; Carrington BM; Hutchison G; Jones AP; Sourbron SP; Buckley DL
Magn Reson Med; 2010 Mar; 63(3):691-700. PubMed ID: 20187179
[TBL] [Abstract][Full Text] [Related]
12. Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI.
Sahoo P; Rathore RK; Awasthi R; Roy B; Verma S; Rathore D; Behari S; Husain M; Husain N; Pandey CM; Mohakud S; Gupta RK
J Magn Reson Imaging; 2013 Sep; 38(3):677-88. PubMed ID: 23390002
[TBL] [Abstract][Full Text] [Related]
13. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI.
Buckley DL
Magn Reson Med; 2002 Mar; 47(3):601-6. PubMed ID: 11870848
[TBL] [Abstract][Full Text] [Related]
14. Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI.
Liu HL; Chang TT; Yan FX; Li CH; Lin YS; Wong AM
NMR Biomed; 2015 Jun; 28(6):642-9. PubMed ID: 25880892
[TBL] [Abstract][Full Text] [Related]
15. Quantification of dynamic contrast-enhanced MR imaging of the knee in children with juvenile rheumatoid arthritis based on pharmacokinetic modeling.
Workie DW; Dardzinski BJ; Graham TB; Laor T; Bommer WA; O'Brien KJ
Magn Reson Imaging; 2004 Nov; 22(9):1201-10. PubMed ID: 15607091
[TBL] [Abstract][Full Text] [Related]
16. Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.
Feng Y; Jeong EK; Mohs AM; Emerson L; Lu ZR
Magn Reson Med; 2008 Dec; 60(6):1347-52. PubMed ID: 19025902
[TBL] [Abstract][Full Text] [Related]
17. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pancreatic cancer by multiple breath-hold dynamic contrast-enhanced magnetic resonance imaging at 3.0T.
Yao X; Zeng M; Wang H; Sun F; Rao S; Ji Y
Eur J Radiol; 2012 Aug; 81(8):e917-22. PubMed ID: 22695786
[TBL] [Abstract][Full Text] [Related]
19. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
